Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19

Official Title

Epidemiological and Clinical Characteristics of Patients With COVID-19 Admitted in Italian Intensive Care Units: a Multicentric Retrospective-prospective Cohort Study.

Brief Summary

Objective of this observational multicentric retrospective-prospective study is to describe the number and the characteristics of patients with Reverse Transcription Polymerase Chain Reaction (RT-PCR) for SARS-CoV2 positivity admitted to Intensive Care Units during the first 6 months of epidemic.

Status

Unknown status

Conditions

COVID-19

Critical Illness

Eligibility Criteria

Inclusion Criteria:

- Adulthood

- Informed consent obtained

Exclusion Criteria:

- No informed consent obtained

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

Italy

Locations

Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Milan, Italy

Investigator: Giacomo Grasselli, MD
Contact: +390255033285
giacomo.grasselli@unimi.it

Contacts

Giacomo Grasselli, MD
+390255033285
giacomo.grasselli@unimi.it

Investigators

Giacomo Grasselli, MD, Principal Investigator
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

NCT Number

NCT04388670

MeSH Terms

COVID-19

Critical Illness

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Policlinico Hospital

Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA